|
AU2015202199A1
|
|
High-throughput assay for evaluating dipeptidyl peptidase I activity
|
|
BRPI0919764A2
|
|
High performance assay for the evaluation of dipeptidyl peptidase i activity
|
|
CN102238968A
|
|
Animal model for evaluating vasomotor response in vivo
|
|
US2006270836A1
|
|
Crystallized structure of estrogen related receptor gamma in complex with bisphenol A
|
|
AU2006200646A1
|
|
A method of modulating cellular activity
|
|
WO2005121160A2
|
|
11, 12 cyclic thiocarbamate macrolide antibacterial agents
|
|
WO2005065351A2
|
|
System and method for visually presenting digital patient information for future drug use resulting from dosage alteration
|
|
US7550474B2
|
|
Substituted phenyl acetamides and their use as protease inhibitors
|
|
EP1549645A1
|
|
4,6-diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors
|
|
EP1546718A2
|
|
Method for determining the regulation of xenobiotic removal
|
|
EP1573447A2
|
|
Methods, systems, and computer program products for representing object relationships in a multidimensional space
|
|
EP1532445A1
|
|
Method for the identification of ligands
|
|
NZ515132A
|
|
Sphingosine kinase enzyme
|
|
US7416524B1
|
|
System, method and computer program product for fast and efficient searching of large chemical libraries
|
|
EP1030678A1
|
|
High throughput method for functionally classifying proteins identified using a genomics approach
|
